Low-Dose Dexamethasone Suppression Test in Chronic Fatigue Syndrome and Health

Objective Subtle dysregulations of the hypothalamus-pituitary-adrenal axis in chronic fatigue syndrome have been described. The aim of this study was to examine the negative feedback regulations of the hypothalamus-pituitary-adrenal axis in chronic fatigue syndrome. Methods In 21 patients with chronic fatigue syndrome and 21 healthy control subjects, awakening and circadian salivary free cortisol profiles were assessed over 2 consecutive days and compared with awakening and circadian salivary free cortisol profiles after administration of 0.5 mg of dexamethasone at 11:00 PM the previous day. Results Patients with chronic fatigue syndrome had normal salivary free cortisol profiles but showed enhanced and prolonged suppression of salivary free cortisol after the administration of 0.5 mg of dexamethasone in comparison to the control subjects. Conclusions Enhanced negative feedback of the hypothalamus-pituitary-adrenal axis could be a plausible explanation for the previously described alterations in hypothalamus-pituitary-adrenal axis functioning in chronic fatigue syndrome. Because similar changes have been described in stress-related disorders, a putative role of stress in the pathogenesis of the enhanced feedback is possible.

[1]  Ian Hickie,et al.  The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study , 1994, Annals of Internal Medicine.

[2]  C. Kirschbaum,et al.  The cortisol response to awakening in relation to different challenge tests and a 12-hour cortisol rhythm. , 1999, Life sciences.

[3]  T. Dinan,et al.  Blunted adrenocorticotropin and Cortisol responses to corticotropin‐releasing hormone stimulation in chronic fatigue syndrome , 1998, Acta psychiatrica Scandinavica.

[4]  M. Stein,et al.  Enhanced Dexamethasone Suppression of Plasma Cortisol in Adult Women Traumatized by Childhood Sexual Abuse , 1997, Biological Psychiatry.

[5]  G. Chrousos,et al.  The endocrinology of melancholic and atypical depression: relation to neurocircuitry and somatic consequences. , 1999, Proceedings of the Association of American Physicians.

[6]  V. Lehtinen,et al.  Self-perceived fatigue and cortisol secretion in a community sample. , 1993, Journal of psychosomatic research.

[7]  Cecilia A. Essau,et al.  DIA-X-Interview , 1999 .

[8]  E. Young,et al.  Differential Regulation of Hippocampal Glucocorticoid Receptors mRNA and Fast Feedback: Relevance to Post‐Traumatic Stress Disorder , 1999, Journal of neuroendocrinology.

[9]  R. Yehuda,et al.  Increased pituitary activation following metyrapone administration in post-traumatic stress disorder , 1996, Psychoneuroendocrinology.

[10]  S. West,et al.  Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. , 1999, The American journal of psychiatry.

[11]  H. Meltzer,et al.  Dexamethasone bioavailability: Implications for DST research , 1987, Biological Psychiatry.

[12]  R. Spencer,et al.  Dexamethasone suppression of corticosteroid secretion: evaluation of the site of action by receptor measures and functional studies , 2000, Psychoneuroendocrinology.

[13]  F. Salaffi,et al.  Neuroendocrinologic findings in primary fibromyalgia (soft tissue chronic pain syndrome) and in other chronic rheumatic conditions (rheumatoid arthritis, low back pain) , 1990, The Journal of rheumatology.

[14]  S. Kessler,et al.  Assessing health in musculoskeletal disorders – the appropriateness of a German version of the Sickness Impact Profile , 1997, Rheumatology International.

[15]  D. Goldenberg,et al.  The dexamethasone suppression test in fibrositis. , 1984, Biological psychiatry.

[16]  B. Carroll,et al.  Dexamethasone metabolism in dexamethasone suppression test suppressors and nonsuppressors , 2000, Biological Psychiatry.

[17]  D. Hellhammer,et al.  Abuse-Related Posttraumatic Stress Disorder and Alterations of the Hypothalamic-Pituitary-Adrenal Axis in Women With Chronic Pelvic Pain , 1998, Psychosomatic medicine.

[18]  B. McEwen,et al.  Corticosterone regulation of Type I and Type II adrenal steroid receptors in brain, pituitary, and immune tissue , 1991, Brain Research.

[19]  P. Onghena,et al.  Victimization in chronic fatigue syndrome and fibromyalgia in tertiary care: a controlled study on prevalence and characteristics. , 2001, Psychosomatics.

[20]  M. Power,et al.  Chronic fatigue in the community: ‘A question of attribution’ , 1996, Psychological Medicine.

[21]  J W Mason,et al.  Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder. , 1993, The American journal of psychiatry.

[22]  T. Dinan,et al.  The low dose ACTH test in chronic fatigue syndrome and in health , 1998, Clinical endocrinology.

[23]  B. Kudielka,et al.  Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis. , 1999, Psychosomatic medicine.

[24]  McCain Ga,et al.  Diurnal hormone variation in fibromyalgia syndrome: a comparison with rheumatoid arthritis. , 1989 .

[25]  C. Kirschbaum,et al.  Free cortisol levels after awakening: a reliable biological marker for the assessment of adrenocortical activity. , 1997, Life sciences.

[26]  M. Joëls,et al.  Brain corticosteroid receptor balance in health and disease. , 1998, Endocrine reviews.

[27]  R. Dolan,et al.  Attributions and self-esteem in depression and chronic fatigue syndromes. , 1990, Journal of psychosomatic research.

[28]  E. Smets,et al.  The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. , 1995, Journal of psychosomatic research.

[29]  C. Ray.  Chronic fatigue syndrome and depression: conceptual and methodological ambiguities , 1991, Psychological Medicine.

[30]  S. Checkley,et al.  Salivary Cortisol Profiles in Chronic Fatigue Syndrome , 1997, Neuropsychobiology.

[31]  E. R. D. Koloet.  Why Dexamethasone Poorly Penetrates in Brain , 1997 .

[32]  E. D. de Kloet,et al.  Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. , 1993, The Journal of rheumatology.

[33]  R. Snaith,et al.  The Hospital Anxiety and Depression Scale , 1983 .

[34]  de Kloet ER.  Why Dexamethasone Poorly Penetrates in Brain. , 1997, Stress.

[35]  G. Bleijenberg,et al.  Dimensional assessment of chronic fatigue syndrome. , 1994, Journal of psychosomatic research.

[36]  E. Lentjes,et al.  Increased Sensitivity to Glucocorticoids in Peripheral Blood Mononuclear Cells of Chronic Fatigue Syndrome Patients, Without Evidence for Altered Density or Affinity of Glucocorticoid Receptors , 2001, Journal of Investigative Medicine.

[37]  M. Sharpe,et al.  A Report–Chronic Fatigue Syndrome: Guidelines for Research , 1991, Journal of the Royal Society of Medicine.

[38]  R. Yehuda,et al.  Basal cortisol, dexamethasone suppression of cortisol, and MHPG in adolescents after the 1988 earthquake in Armenia. , 1996, The American journal of psychiatry.

[39]  T. Theorell,et al.  Critical life events, infections, and symptoms during the year preceding chronic fatigue syndrome (CFS): an examination of CFS patients and subjects with a nonspecific life crisis. , 1999, Psychosomatic medicine.

[40]  I. Liberzon,et al.  Stress-restress: Effects on ACTH and fast feedback , 1997, Psychoneuroendocrinology.

[41]  S. Wessely,et al.  Contrasting neuroendocrine responses in depression and chronic fatigue syndrome , 1995, Biological Psychiatry.

[42]  G. Chrousos,et al.  Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. , 1997, Neuroimmunomodulation.

[43]  D. Hellhammer,et al.  The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders , 2000, Psychoneuroendocrinology.

[44]  M. Demitrack,et al.  Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. , 1991, The Journal of clinical endocrinology and metabolism.

[45]  C. Kirschbaum,et al.  Burnout, perceived stress, and cortisol responses to awakening. , 1999, Psychosomatic medicine.

[46]  I. Hickie,et al.  The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. , 1994, Annals of internal medicine.

[47]  T. Dinan,et al.  Urinary free cortisol excretion in chronic fatigue syndrome, major depression and in healthy volunteers. , 1998, Journal of affective disorders.

[48]  E. Giller,et al.  Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder. , 1995, Archives of general psychiatry.

[49]  P. Garfinkel,et al.  Depression in Patients with Neuromyasthenia (Benign Myalgic Encephalomyelitis) , 1988, International journal of psychiatry in medicine.

[50]  M. Demitrack,et al.  Chronic Fatigue Syndrome: An Integrative Approach to Evaluation and Treatment , 1999 .

[51]  W. Katon,et al.  Adult health status of women with histories of childhood abuse and neglect. , 1999, The American journal of medicine.

[52]  W. M. Jefferies,et al.  Mild adrenocortical deficiency, chronic allergies, autoimmune disorders and the chronic fatigue syndrome: a continuation of the cortisone story. , 1994, Medical hypotheses.

[53]  G. A. Mccain,et al.  Diurnal hormone variation in fibromyalgia syndrome: a comparison with rheumatoid arthritis. , 1989, The Journal of rheumatology. Supplement.

[54]  G. Johnson,et al.  Effect of high plasma dexamethasone levels on DST sensitivity: Dose-response study in depressed patients and controls , 1991, Psychiatry Research.

[55]  I. Salit.  Precipitating factors for the chronic fatigue syndrome. , 1997, Journal of psychiatric research.

[56]  C. Kirschbaum,et al.  Tissue specificity of glucocorticoid sensitivity in healthy adults. , 2000, The Journal of clinical endocrinology and metabolism.

[57]  A. Cleare,et al.  The 1μg short Synacthen test in chronic fatigue syndrome , 1999 .

[58]  C. Kirschbaum,et al.  Synthesis of a cortisol-biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement , 1992, The Journal of Steroid Biochemistry and Molecular Biology.